Abstract
Background: Type 2 diabetes (adult onset diabetes) is the most common type of diabetes, accounting for around 90% of all diabetes cases with insulin resistance and insulin secretion defect. The key goal of anti-diabetic therapy is to increase the development of insulin, immunity and/or decrease the amount of blood glucose. While many synthetic compounds have been produced as antidiabetic agents, due to their side effects and limited effectiveness, their usefulness has been hindered.
Methods: This systematic review investigated the bioactive compounds reported to possess activities against type 2 diabetes. Three (3) databases, PubMed, ScienceDirect and Google Scholar were searched for research articles published between January 2010 and October 2020. A total of 6464 articles were identified out of which 84 articles were identified to be elligible for the study.
Result and Discussion: From the data extracted, it was found that quercetin, Kaempferol, Rosmarinic acid, Cyanidin, Rutin, Catechin, Luteolin and Ellagic acid were the most cited bioactive compounds which all falls within the class of polyphenolic compounds. The major sources of these bioactive compounds includes citrus fruits, grapes, onions, berries, cherries, broccoli, honey, apples, green tea, Ginkgo biloba, St. John's wort, green beans, cucumber, spinach, tea, Rosmarinus officinalis, Aloe vera, Moringa oleifera, tomatoes, potatoes, oregano, lemon balm, thyme, peppermint, Ocimum basilicum, red cabbage, pears, olive oil and walnut.
Keywords: Type 2 diabetes, (T2DM), Anti-diabetic agents, Bioactive compounds, Phytochemicals, Medicinal plants, Polyphenols, Flavonoids.
Current Topics in Medicinal Chemistry
Title:Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review
Volume: 21 Issue: 12
Author(s): Chukwuebuka Egbuna*, Chinaza G. Awuchi, Garima Kushwaha, Mithun Rudrapal, Kingsley C. Patrick-Iwuanyanwu, Omkar Singh, Uchenna E. Odoh, Johra Khan, Jaison Jeevanandam, Suresh Kumarasamy, Vincent O. Chukwube, Mathiyazhagan Narayanan, Santwana Palai, Mihnea-Alexandru Găman, Chukwuemelie Z. Uche, Daprim S. Ogaji, Nebechi J. Ezeofor, Andrew G. Mtewa, Chinyere C. Patrick-Iwuanyanwu, Shyam S. Kesh, Chandan Shivamallu, Kaliyaperumal Saravanan, Habibu Tijjani, Muhammad Akram, Jonathan C. Ifemeje, Michael C. Olisah and Chukwudi J. Chikwendu
Affiliation:
- World Bank Africa Centre of Excellence in Public Health and Toxicological Research (PUTOR), University of Port-Harcourt, Rivers State,Nigeria
Keywords: Type 2 diabetes, (T2DM), Anti-diabetic agents, Bioactive compounds, Phytochemicals, Medicinal plants, Polyphenols, Flavonoids.
Abstract:
Background: Type 2 diabetes (adult onset diabetes) is the most common type of diabetes, accounting for around 90% of all diabetes cases with insulin resistance and insulin secretion defect. The key goal of anti-diabetic therapy is to increase the development of insulin, immunity and/or decrease the amount of blood glucose. While many synthetic compounds have been produced as antidiabetic agents, due to their side effects and limited effectiveness, their usefulness has been hindered.
Methods: This systematic review investigated the bioactive compounds reported to possess activities against type 2 diabetes. Three (3) databases, PubMed, ScienceDirect and Google Scholar were searched for research articles published between January 2010 and October 2020. A total of 6464 articles were identified out of which 84 articles were identified to be elligible for the study.
Result and Discussion: From the data extracted, it was found that quercetin, Kaempferol, Rosmarinic acid, Cyanidin, Rutin, Catechin, Luteolin and Ellagic acid were the most cited bioactive compounds which all falls within the class of polyphenolic compounds. The major sources of these bioactive compounds includes citrus fruits, grapes, onions, berries, cherries, broccoli, honey, apples, green tea, Ginkgo biloba, St. John's wort, green beans, cucumber, spinach, tea, Rosmarinus officinalis, Aloe vera, Moringa oleifera, tomatoes, potatoes, oregano, lemon balm, thyme, peppermint, Ocimum basilicum, red cabbage, pears, olive oil and walnut.
Export Options
About this article
Cite this article as:
Egbuna Chukwuebuka*, Awuchi G. Chinaza, Kushwaha Garima, Rudrapal Mithun, Patrick-Iwuanyanwu C. Kingsley, Singh Omkar, Odoh E. Uchenna, Khan Johra, Jeevanandam Jaison, Kumarasamy Suresh, Chukwube O. Vincent, Narayanan Mathiyazhagan, Palai Santwana, Găman Mihnea-Alexandru, Uche Z. Chukwuemelie, Ogaji S. Daprim, Ezeofor J. Nebechi, Mtewa G. Andrew, Patrick-Iwuanyanwu C. Chinyere, Kesh S. Shyam, Shivamallu Chandan, Saravanan Kaliyaperumal, Tijjani Habibu, Akram Muhammad, Ifemeje C. Jonathan, Olisah C. Michael and Chikwendu J. Chukwudi, Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review, Current Topics in Medicinal Chemistry 2021; 21 (12) . https://dx.doi.org/10.2174/1568026621666210509161059
DOI https://dx.doi.org/10.2174/1568026621666210509161059 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Chronic Kidney Disease
The scope of the special thematic issue includes but not limited to the mechanism of chronic kidney disease (CKD), the treatment of renal fibrosis and early diagnosis of CKD and so on. We also welcome manuscripts from other scientific research area with respect to internal medicine. Cell death has been ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epidemiology of Major Congenital Malformations with Specific Focus on Teratogens
Current Drug Safety Remote Control of Pulmonary Blood Flow
Current Cardiology Reviews Epigenetics in Vascular Disease – Therapeutic Potential of New Agents
Current Vascular Pharmacology Recent Advances in Drug Repurposing for Parkinson’s Disease
Current Medicinal Chemistry Understanding Respiratory Syncytial Virus Infection to Improve Treatment and Immunity
Current Molecular Medicine Role of Hexokinase and VDAC in Neurological Disorders
Current Molecular Pharmacology Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
Current Signal Transduction Therapy Congenital Malformations Attributed to Prenatal Exposure to Cyclophosphamide
Anti-Cancer Agents in Medicinal Chemistry RNA Sensors as a Mechanism of Innate Immune Evasion among SARSCoV2, HIV and Nipah Viruses
Current Protein & Peptide Science The Role of Transforming Growth Factor β1 in the Regulation of Blood Pressure
Current Hypertension Reviews Coated with Nanomaterials Intraocular Lenses, Ophthalmic and Human Body Implantable Devices with High Catalytic Antioxidant Activities: A New Nanotechnology Strategy of Peroxidase Cellular Enzyme Mimics Increasing the Biocompatibility and Therapeutic Deployment of the Medical Prosthetic Device
Recent Patents on Drug Delivery & Formulation Children with Chronic Kidney Disease and Hypertension: Could Hypertension Footprints be Early Biomarkers?
Current Hypertension Reviews Development and Clinical use of Prasugrel and Ticagrelor
Current Pharmaceutical Design Fgf10: A Paracrine-Signaling Molecule in Development, Disease, and Regenerative Medicine
Current Molecular Medicine Cardiovascular Drugs Inducing QT Prolongation: Facts and Evidence
Current Drug Safety The Coronin Family and Human Disease
Current Protein & Peptide Science The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
Current Drug Discovery Technologies Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Psychoemotional Background of Temporomandibular Joint Dysfunction and Possible Drug Therapy
Letters in Drug Design & Discovery